Summitry LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,475
Closed -$252K 88
2016
Q3
$252K Hold
5,475
0.03% 78
2016
Q2
$275K Hold
5,475
0.03% 74
2016
Q1
$293K Sell
5,475
-3,407
-38% -$200K 0.03% 73
2015
Q4
$478K Buy
8,882
+1,600
+22% +$98.9K 0.05% 56
2015
Q3
$411K Sell
7,282
-3,965
-35% -$257K 0.05% 54
2015
Q2
$658K Sell
11,247
-252,702
-96% -$15.6M 0.08% 41
2015
Q1
$16.4M Sell
263,949
-179,532
-40% -$10.4M 1.92% 27
2014
Q4
$25.5M Buy
443,481
+655
+0.1% +$36.5K 2.82% 16
2014
Q3
$23.8M Buy
442,826
+1,553
+0.4% +$82.3K 2.95% 13
2014
Q2
$23.1M Buy
441,273
+5,000
+1% +$256K 2.94% 15
2014
Q1
$23.1M Buy
436,273
+6,315
+1% +$292K 2.97% 11
2013
Q4
$17.2M Buy
429,958
+24,054
+6% +$947K 2.27% 21
2013
Q3
$15.3M Buy
405,904
+9,573
+2% +$373K 2.32% 22
2013
Q2
$15.5M Buy
+396,331
New +$15.4M 2.44% 22

Other funds holding TEVA